Hepatocellular carcinoma recurrence after directly-acting antiviral therapy: caution with hepatitis C

被引:0
|
作者
Ng, Alexander [1 ]
机构
[1] UCL, Fac Laws, Gower St, London WC1E 6BT, England
关键词
D O I
10.1097/MEG.0000000000002193
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:E1091 / E1092
页数:2
相关论文
共 50 条
  • [31] Hepatocellular carcinoma recurrence after directly acting antivirals for chronic hepatitis C: a 2-year follow-up study
    Kamal, Ahmed
    Elmoety, Amr Aly Abd
    Rostom, Yousri Abdelmeguid
    Shater, Mohamed Said
    Lashen, Sameh Aldesoky
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 7 (01) : 66 - 73
  • [32] Rapidly growing hepatocellular carcinoma recurrence during direct-acting antiviral treatment for chronic hepatitis C
    Yamashita N.
    Tanimoto H.
    Shimoda S.
    Komori A.
    Nomura H.
    Clinical Journal of Gastroenterology, 2018, 11 (6) : 497 - 500
  • [33] Quality of life improvement after directly acting antiviral therapy in chronic hepatitis C infected patients
    Sharma, Mridula
    Mahajan, Nikhil
    Patil, Mahesh
    Ratnaparkhi, Gaurav
    Reddy, Sunil
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 574 - 574
  • [34] Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis
    Ravi, Sujan
    Axley, Page
    Jones, Deann
    Kodali, Sudha
    Simpson, Heather
    McGuire, Brendan M.
    Singal, Ashwani K.
    GASTROENTEROLOGY, 2017, 152 (04) : 911 - 912
  • [35] Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy
    Pillai, Anjana A.
    Anania, Frank A.
    Pearlman, Brian L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (12): : 1854 - 1856
  • [36] Antiviral Therapy in Patients after Treatment for Hepatitis C-Related Hepatocellular Carcinoma
    Shin, Su Rin
    Paik, Seung Woon
    Gwak, Geum-Youn
    Choi, Moon Seok
    Lee, Joon Hyoek
    Koh, Kwang Cheol
    Yoo, Byung Chul
    GUT AND LIVER, 2011, 5 (01) : 77 - 81
  • [37] Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus (HCV) Liver Transplant Recipients Treated with Pretransplant Direct-Acting Antiviral (DAA) Therapy
    Lim, Nicholas
    Singh, Dupinder
    Jackson, Scott
    Lake, John R.
    GASTROINTESTINAL TUMORS, 2020, 7 (04) : 134 - 143
  • [38] Direct-acting antiviral therapy reduces the recurrence risk in patients with hepatitis C virus-related early stage hepatocellular carcinoma after curative resection
    Huang, Kuo-Hsuan
    Chen, Chien-Hung
    Hung, Chao-Hung
    Wang, Jing-Houng
    Tsai, Tsung Ming-Chao
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 259 - 260
  • [39] Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs
    Yang, Caiyun
    Lv, Fengxiang
    Yang, Jiaqi
    Ding, Dawei
    Cui, Lina
    Han, Ying
    ANNALS OF HEPATOLOGY, 2025, 30 (02)
  • [40] Hepatocellular carcinoma after direct-acting antiviral drug treatment in patients with hepatitis C virus
    Kogiso, Tomomi
    Sagawa, Takaomi
    Kodama, Kazuhisa
    Taniai, Makiko
    Katagiri, Satoshi
    Egawa, Hiroto
    Yamamoto, Masakazu
    Tokushige, Katsutoshi
    JGH OPEN, 2019, 3 (01): : 52 - 60